Mechanical heart valves have improved long-term survival benefit over biological valves for patients aged 50-70 years, new ...

Rising prevalence of cardiovascular diseases and rapid advancements in minimally invasive procedures are fueling the growth ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...

Patients with aortic stenosis were excluded from earlier trials of the SGLT2 inhibitor, but new data confirm they too can ...

She also pointed out that bicuspid aortic stenosis has generally ... 60 years of age or younger treated with a mechanical rather than a bioprosthetic valve after follow-up of up to 12 years.

Patients at IJN have two options: the On-X Ascending Aortic Prosthesis (On-X AAP), a mechanical valve made of carbon and metal, and the Konect Tissue Valve, a bioprosthetic made from cow tissue.

As heart failure patients, the TAVI population studied already is recommended to be treated with an SGLT2 inhibitor, noted ...

Cardiac and major vascular surgeries are intricate and high-risk procedures known for significant morbidity and mortality ...

Your aortic valve may be replaced by a mechanical valve or a biological valve. A mechanical valve will last longer but you need to take anticoagulant medicines for the rest of your life to prevent ...